Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2CNS 1

Conditions

Leukemia, Myeloid, Acute 75Burkitt Lymphoma 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Leukemia, Biphenotypic, Acute 16Myelodysplastic Syndromes 13Leukemia 10Lymphoma, Mantle-Cell 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Leukemia, Myelomonocytic, Chronic 5Recurrence 4Blast Crisis 4Sarcoma, Myeloid 3Lymphoma 3Leukemia, Monocytic, Acute 3Hematologic Neoplasms 3Down Syndrome 3Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myeloid 2Hodgkin Disease 2Anemia, Refractory, with Excess of Blasts 2Thrombocythemia, Essential 1Targeted Therapy 1

Interventions

fludarabine 6Cyclophosphamide 4fludarabine phosphate 3trametinib 2thymoglobulin 2Specimen Handling 2Melphalan 2Cytarabine 2Busulfan 2Biopsy 2omipalisib 1merphos 1imetelstat 1hydrocortisone hemisuccinate 1blinatumomab 1Whole-Body Irradiation 1Transplantation 1Thiotepa 1Tacrolimus 1Spinal Puncture 1Rituximab 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Mesna 1Levetiracetam 1Leucovorin 1Injections 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Myelomonocytic, Juvenile × Cytarabine × 90 days × Clear all
NCT06247787 2026-04-20

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

Children's Oncology Group

Phase 1 Recruiting
36 enrolled
Other hematologic neoplasm

Leukemia, Myelomonocytic, Juvenile

NCT05849662 2026-04-15

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1/2 Recruiting
58 enrolled
CNSOther hematologic neoplasm

Neurofibromatosis 1, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡